CLINICAL_TRIALS
research
· 2026-04-02
Clinical Trial Update: MHB018A Treatment in Patients With Active Thyroid Eye Disease [Phase 3]
Summary
A Phase 3 clinical trial evaluating MHB018A for active thyroid-associated ophthalmopathy is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd | Conditions: Thyroid Associated Ophthalmopathies | Phase 3 | Status: RECRUITING